{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:58:49Z","timestamp":1791575929788,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFA0110802"],"award-info":[{"award-number":["2019YFA0110802"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970121"],"award-info":[{"award-number":["81970121"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270152"],"award-info":[{"award-number":["82270152"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-003"],"award-info":[{"award-number":["2021-I2M-1-003"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2022-I2M-2-003"],"award-info":[{"award-number":["2022-I2M-2-003"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jtha.2023.01.040","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:52:32Z","timestamp":1676393552000},"page":"1453-1465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Preclinical studies of a factor X activator and a phase 1 trial for hemophilia patients with inhibitors"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4713-2441","authenticated-orcid":false,"given":"Wei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5947-3924","authenticated-orcid":false,"given":"Feng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5442-1028","authenticated-orcid":false,"given":"Rongfeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mankai","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanrui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5259-1429","authenticated-orcid":false,"given":"Hu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3741-8518","authenticated-orcid":false,"given":"Renchi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7769-7377","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.01.040_bib1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminhematol.2006.03.006","article-title":"Overview of inhibitors","volume":"43","author":"Astermark","year":"2006","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtha.2023.01.040_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.2006.06359.x","article-title":"Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors","volume":"136","author":"Reipert","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.01.040_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/hae.12466","article-title":"ITI choice for the optimal management of inhibitor patients - from a clinical and pharmacoeconomic perspective","volume":"20","author":"Oldenburg","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.01.040_bib4","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3389\/fimmu.2019.02991","article-title":"Tolerating factor VIII: recent progress","volume":"10","author":"Lacroix-Desmazes","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2023.01.040_bib5","doi-asserted-by":"crossref","unstructured":"Collins PW, Chalmers E, Hart DP, Liesner R, Rangarajan S, Talks K, Williams M, Hay CR. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization. Br J Haematol 2013;160:153\u2013170.","DOI":"10.1111\/bjh.12091"},{"key":"10.1016\/j.jtha.2023.01.040_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0037-1612943","article-title":"The North American Immune Tolerance Registry: practices, outcomes, outcome predictors","volume":"87","author":"DiMichele","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.040_bib7","doi-asserted-by":"crossref","unstructured":"Srivastava A, Santagostino E, Dougall A, Kitchen S, Sutherland M, Pipe SW, Carcao M, Mahlangu J, Ragni MV, Windyga J, Llin\u00e1s A, Goddard NJ, Mohan R, Poonnoose PM, Feldman BM, Lewis SZ, van den Berg HM, Pierce GF. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia 2020;26:1\u2013158.","DOI":"10.1111\/hae.14046"},{"key":"10.1016\/j.jtha.2023.01.040_bib8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1365-2516.2002.00626.x","article-title":"Inhibitors: resolving diagnostic and therapeutic dilemmas","volume":"8","author":"Dimichele","year":"2002","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.01.040_bib9","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1365-2516.2009.02039.x","article-title":"Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997\u20132006)","volume":"15","author":"Chitlur","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.01.040_bib10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-0037-1612626","article-title":"Inhibitors in hemophilia: treatment challenges and novel options","volume":"44","author":"Barg","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.01.040_bib11","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood-2017-08-801662","article-title":"Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII?","volume":"130","author":"Lenting","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.040_bib12","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/nm.2942","article-title":"A\u00a0bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model","volume":"18","author":"Kitazawa","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jtha.2023.01.040_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1703068","article-title":"Emicizumab prophylaxis in hemophilia A with inhibitors","volume":"377","author":"Oldenburg","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.01.040_bib14","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMc1909742","article-title":"Deaths associated with emicizumab in patients with hemophilia A","volume":"381","author":"Aledort","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.01.040_bib15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/jth.12864","article-title":"Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial","volume":"13","author":"Chowdary","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.040_bib16","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/jth.14272","article-title":"A\u00a0randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A","volume":"16","author":"Eichler","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.040_bib17","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1616569","article-title":"Targeting of antithrombin in hemophilia A or B with RNAi therapy","volume":"377","author":"Pasi","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.01.040_bib18","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1182\/blood.V128.22.2572.2572","article-title":"Fitusiran, an investigational RNAi therapeutic targeting antithrombin for the treatment of hemophilia: updated results from a phase 1 and phase 1\/2 extension study in patients without inhibitors","volume":"128","author":"Ragni","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.040_bib19","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1182\/blood.2019001542","article-title":"Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A\/B with inhibitors: phase 2 trial results","volume":"134","author":"Shapiro","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.040_bib20","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0049-3848(16)30360-7","article-title":"Bioengineering factor Xa to treat bleeding","volume":"141","author":"Camire","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.01.040_bib21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1182\/blood-2015-03-634329","article-title":"Hemostatic agents of broad applicability produced by selective tuning of factor Xa zymogenicity","volume":"126","author":"Ivanciu","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.040_bib22","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nbt.1995","article-title":"A\u00a0zymogen-like factor Xa variant corrects the coagulation defect in hemophilia","volume":"29","author":"Ivanciu","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jtha.2023.01.040_bib23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1182\/blood-2010-08-300756","article-title":"Zymogen-like factor Xa variants restore thrombin generation and effectively bypass the intrinsic pathway in\u00a0vitro","volume":"117","author":"Bunce","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.01.040_bib24","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/jth.13059","article-title":"Correction of human hemophilia A whole blood abnormalities with a novel bypass agent: zymogen-like FXa(I16L)","volume":"13","author":"George","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.040_bib25","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/jth.13673","article-title":"Phase 1 dose-escalating study to evaluate the safety, pharmacokinetics, and pharmacodynamics of a recombinant factor Xa variant (FXaI16L)","volume":"15","author":"Parsons-Rich","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.040_bib26","doi-asserted-by":"crossref","first-page":"10644","DOI":"10.1016\/S0021-9258(17)34108-X","article-title":"Factor X-activating glycoprotein of Russell\u2019s viper venom. Polypeptide composition and characterization of the carbohydrate moieties","volume":"269","author":"Gowda","year":"1994","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.01.040_bib27","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1016\/j.febslet.2007.11.062","article-title":"Crystal structure of RVV-X: an example of evolutionary gain of specificity by ADAM proteinases","volume":"581","author":"Takeda","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jtha.2023.01.040_bib28","first-page":"225","article-title":"Snake venom activators of factor X: an overview","volume":"31","author":"Tans","year":"2001","journal-title":"Haemostasis"},{"key":"10.1016\/j.jtha.2023.01.040_bib29","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1021\/cr000033x","article-title":"Serine protease mechanism and specificity","volume":"102","author":"Hedstrom","year":"2002","journal-title":"Chem Rev"},{"key":"10.1016\/j.jtha.2023.01.040_bib30","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/glycob\/cwt085","article-title":"N-\/O-glycosylation analysis of human FVIIa produced in the milk of transgenic rabbits","volume":"23","author":"Chevreux","year":"2013","journal-title":"Glycobiology"},{"key":"10.1016\/j.jtha.2023.01.040_bib31","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/bjh.17322","article-title":"Patients with haemophilia A with inhibitors in China: a national real-world analysis and follow-up","volume":"192","author":"Dou","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.01.040_bib32","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/hae.13312","article-title":"The pharmacokinetics and pharmacodynamics of single-dose and multiple-dose recombinant activated factor VII in patients\u00a0with haemophilia A or B","volume":"23","author":"Fern\u00e1ndez-Bello","year":"2017","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.01.040_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/hae.14253","article-title":"Exploratory in\u00a0vitro evaluation of thrombin generation of eptacog beta (recombinant human FVIIa) and emicizumab in congenital haemophilia A plasma","volume":"27","author":"Grandoni","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.01.040_bib34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000071637","article-title":"Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay","volume":"33","author":"Turecek","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.jtha.2023.01.040_bib35","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/jth.12287","article-title":"Towards standardization of clot waveform analysis and recommendations for its clinical applications","volume":"11","author":"Shima","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.040_bib36","first-page":"30","article-title":"Thrombin generation assay as a laboratory monitoring tool during bypassing therapy in patients with hemophilia and inhibitors","volume":"42","author":"Mancuso","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.01.040_bib37","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1111\/hae.12309","article-title":"Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors","volume":"20","author":"Luna-Z\u00e1izar","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.01.040_bib38","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1111\/j.1538-7836.2007.02663.x","article-title":"Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors","volume":"5","author":"Konkle","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.01.040_bib39","first-page":"CD011441","article-title":"Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors","volume":"9","author":"Chai-Adisaksopha","year":"2017","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623001484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623001484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:37:48Z","timestamp":1761536268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623001484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1538783623001484"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.01.040","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical studies of a factor X activator and a phase 1 trial for hemophilia patients with inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.01.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}